Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susie Min

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
JCI Insight|October 8, 2025
Unique epithelial proliferative transcriptomic signature in proton pump inhibitor-responsive pediatric eosinophilic esophagitisSomdutta Chakraborty, Ankit Sharma, Sahiti Marella, et al.
Plos Pathogens|December 8, 2023
The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin ⍺4β7Donald Van Ryk, Sinmanus Vimonpatranon, Joe Hiatt, et al.
Science (New York, N.Y.)|September 7, 2019
Blocking α<sub>4</sub>β<sub>7</sub> integrin binding to SIV does not improve virologic controlNami Iwamoto, Rosemarie D Mason, Kaimei Song, et al.
JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Iscience|February 8, 2021
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidatesIsabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
JCI Insight|October 8, 2025
Unique epithelial proliferative transcriptomic signature in proton pump inhibitor-responsive pediatric eosinophilic esophagitisSomdutta Chakraborty, Ankit Sharma, Sahiti Marella, et al.
Plos Pathogens|December 8, 2023
The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin ⍺4β7Donald Van Ryk, Sinmanus Vimonpatranon, Joe Hiatt, et al.
Science (New York, N.Y.)|September 7, 2019
Blocking α<sub>4</sub>β<sub>7</sub> integrin binding to SIV does not improve virologic controlNami Iwamoto, Rosemarie D Mason, Kaimei Song, et al.
JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Iscience|February 8, 2021
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidatesIsabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, et al.
Pageof 2